Beijing Historical Cash Flow
| 603392 Stock | 76.65 0.75 0.99% |
Analysis of Beijing Wantai cash flow over time is an excellent tool to project Beijing Wantai Biological future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Total Cash From Operating Activities of 1.2 B or Net Income of 1.3 B as it is a great indicator of Beijing Wantai ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Beijing Wantai Biological latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Beijing Wantai Biological is a good buy for the upcoming year.
Beijing |
About Beijing Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Beijing balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Beijing's non-liquid assets can be easily converted into cash.
Beijing Wantai Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Beijing Wantai Biological to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Beijing Wantai operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Beijing Wantai Biological financial statement analysis. It represents the amount of money remaining after all of Beijing Wantai Biological operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Change To Inventory
The increase or decrease in the amount of inventory a company has over a certain period.Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Beijing Wantai's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Beijing Wantai Biological current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beijing Wantai Biological. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Beijing Wantai's Net Income is projected to increase significantly based on the last few years of reporting. The current year's End Period Cash Flow is expected to grow to about 4 B, whereas Investments are projected to grow to (2 B).
Beijing Wantai cash flow statement Correlations
Click cells to compare fundamentals
Beijing Wantai Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Beijing Wantai cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Investments | (48.2M) | 86.5M | 14.4M | (2.6B) | (2.1B) | (2.0B) | |
| Change In Cash | 69.4M | 543.6M | 711.9M | 3.8B | (1.4B) | (1.3B) | |
| Total Cashflows From Investing Activities | (198.4M) | (295.4M) | (1.0B) | (3.5B) | (3.2B) | (3.0B) | |
| Other Cashflows From Financing Activities | (4.1M) | (17.4M) | 7.2M | (5.1M) | (4.6M) | (4.3M) | |
| Capital Expenditures | 162.0M | 390.4M | 1.0B | 929.9M | 1.2B | 588.7M | |
| Total Cash From Operating Activities | 272.7M | 468.2M | 1.7B | 4.1B | 1.5B | 1.2B | |
| Net Income | 208.9M | 677.0M | 2.0B | 4.7B | 1.2B | 1.3B | |
| End Period Cash Flow | 157.9M | 701.5M | 1.4B | 5.2B | 3.8B | 4.0B | |
| Other Cashflows From Investing Activities | 11.2M | 5.8M | 11.1M | 3.9M | 4.5M | 4.7M | |
| Change To Netincome | 5.3M | 56.9M | 170.5M | 176.9M | 203.4M | 213.6M | |
| Change To Liabilities | 107.7M | 325.7M | 1.3B | 1.1B | 1.3B | 1.4B | |
| Free Cash Flow | 110.7M | 77.8M | 634.2M | 3.2B | 378.2M | 675.4M | |
| Change In Working Capital | 5.9M | (390.6M) | (620.3M) | (938.6M) | (278.3M) | (292.2M) | |
| Begin Period Cash Flow | 88.5M | 157.9M | 701.5M | 1.4B | 5.2B | 5.4B | |
| Depreciation | 80.5M | 84.5M | 105.3M | 148.7M | 231.5M | 243.1M | |
| Other Non Cash Items | (5.0M) | 14.9M | 14.8M | (12.0M) | 23.3M | 24.5M | |
| Dividends Paid | 1.0M | 1.7M | 112.7M | 128.1M | 907.5M | 952.8M | |
| Total Cash From Financing Activities | (5.2M) | 379.8M | 52.8M | 3.1B | 3.6B | 3.8B |
Currently Active Assets on Macroaxis
Other Information on Investing in Beijing Stock
The Cash Flow Statement is a financial statement that shows how changes in Beijing balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Beijing's non-liquid assets can be easily converted into cash.